2 1 Nanocumin Limited 13663394 false 2022-11-01 2024-03-31 2024-03-31 The principal activity of the company is sale of wellness products. Digita Accounts Production Advanced 6.30.9574.0 true 13663394 2022-11-01 2024-03-31 13663394 2024-03-31 13663394 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 13663394 bus:Micro-entities 2022-11-01 2024-03-31 13663394 bus:AuditExemptWithAccountantsReport 2022-11-01 2024-03-31 13663394 bus:FilletedAccounts 2022-11-01 2024-03-31 13663394 bus:SmallCompaniesRegimeForAccounts 2022-11-01 2024-03-31 13663394 bus:RegisteredOffice 2022-11-01 2024-03-31 13663394 bus:Director1 2022-11-01 2024-03-31 13663394 bus:PrivateLimitedCompanyLtd 2022-11-01 2024-03-31 13663394 countries:EnglandWales 2022-11-01 2024-03-31 13663394 2021-10-05 2022-10-31 13663394 2022-10-31 13663394 core:CurrentFinancialInstruments core:WithinOneYear 2022-10-31 xbrli:pure iso4217:GBP

Registration number: 13663394

Nanocumin Limited

Unaudited Financial Statements

for the Period from 1 November 2022 to 31 March 2024

 

Nanocumin Limited

Contents

Balance Sheet

1 to 2

Notes to the Unaudited Financial Statements

1

 

Nanocumin Limited

(Registration number: 13663394)
Balance Sheet as at 31 March 2024

2024
$

2022
$

Current assets

53,526

34,133

Prepayments and accrued income

1,499

2,560

Creditors: Amounts falling due within one year

(116,496)

(48,989)

Total assets less current liabilities

(61,471)

(12,296)

Accruals and deferred income

(1,909)

(1,658)

 

(63,380)

(13,954)

Capital and reserves

(63,380)

(13,954)

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
105 Uphill Road
Mill Hill
London
NW7 4QD

These financial statements were authorised for issue by the Board on 28 March 2025.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'. The functional currency used in preparation of these financial statements is US dollars.

2

Staff numbers

The average number of persons employed by the company (including directors) during the period, was 2 (2022 - 1).

For the financial period ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the micro entities regime and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

 

Nanocumin Limited

(Registration number: 13663394)
Balance Sheet as at 31 March 2024

Approved and authorised by the Board on 28 March 2025 and signed on its behalf by:
 

.........................................
Mr Jonathan Sciama
Director